Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MRNA - Is Novavax Stock A Buy Sell Or Hold After Recent Earnings?

MRNA - Is Novavax Stock A Buy Sell Or Hold After Recent Earnings?

Moderna Inc.
  • COVID is not over, but the situation for the many vaccine developers late to the party (including Novavax) is unclear.
  • There is significant ambiguity about what actual demand for the Novavax vaccine is; I don’t see ~2 billion doses as firm commitments.
  • Gavi/COVAX was seen to be a 1.1 billion dose market for Novavax, but this appears to be disappearing.
  • Adverse events for Novavax vaccine may be similar to those for mRNA vaccines.
  • Novavax’s 2022 guidance of $4-$5 billion revenue looks problematic.

For further details see:

Is Novavax Stock A Buy, Sell, Or Hold After Recent Earnings?
Stock Information
Company Name: Moderna Inc.
Stock Symbol: MRNA
Market: NASDAQ
Website: modernatx.com
Menu
MRNA MRNA Quote MRNA Short MRNA News MRNA Articles MRNA Message Board
Get MRNA Alerts

News, Short Squeeze, Breakout and More Instantly...